SCHEMBL133135

SCHEMBL133135

CCOC(=O)[C@@H]1CCCN1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PRCP P42785 2/20 0.45
DPP7 Q9UHL4 2/20 0.40
SCN4A P35499 1/20 0.40
NOS2 P35228 2/20 0.39
NOS3 P29474 1/20 0.39
NOS1 P29475 1/20 0.39
SLC6A2 P23975 3/20 0.39
SLC6A3 Q01959 3/20 0.39
SLC6A4 P31645 2/20 0.39
DPP4 P27487 1/20 0.39
FAP Q12884 1/20 0.39
DPP8 Q6V1X1 1/20 0.39
DPP9 Q86TI2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
PPM1B O75688 1/20 0.39
PTPN1 P18031 1/20 0.39
PPP1CC P36873 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3330660 1.00 PRCP (0.45) PRCPDPP7SCN4ANOS2NOS3
SCHEMBL10829027 1.00 PRCP (0.45) PRCPDPP7SCN4ANOS2NOS3
SCHEMBL115996 1.00 PRCP (0.45) PRCPDPP7SCN4ANOS2NOS3
Ammonia Solution, Strong SCHEMBL6516951 0.98 PRCP (0.44) PRCPDPP7SCN4ANOS2NOS3
Hydrochloric Acid SCHEMBL1073479 0.98 PRCP (0.44) PRCPDPP7SCN4ANOS2NOS3
Hydrochloric Acid SCHEMBL3530351 0.98 PRCP (0.44) PRCPDPP7SCN4ANOS2NOS3
Hydrochloric Acid SCHEMBL133134 0.98 PRCP (0.44) PRCPDPP7SCN4ANOS2NOS3
Azetidine SCHEMBL18917062 0.96 PRCP (0.43) PRCPDPP7SCN4ANOS2NOS3
SCHEMBL135813 0.94 SLC6A2 (0.44) PRCPSLC6A2SLC6A3SLC6A4ALDH1A1
SCHEMBL1929065 0.94 SLC6A2 (0.44) PRCPSLC6A2SLC6A3SLC6A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 443 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4673426-A1 FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE Locus Solutions IPCO, LLC (US) 2026-01-07 EP claimed
CN-119470406-A Phthalic dicarboxaldehyde disinfectant concentration detection test paper and preparation method thereof 山东新华莎罗雅生物技术有限公司 2025-02-18 CN claimed
US-20240301322-A1 FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE LOCUS SOLUTIONS IPCO LLC (US) 2024-09-12 US claimed
WO-2024182125-A1 FUNCTIONALIZED BIODEGRADABLE SURFACTANTS AND METHODS USE LOCUS SOLUTIONS IPCO, LLC (US) 2024-09-06 WO claimed
CN-115267021-B Liquid chromatographic analysis method for L-prolyl amide related substances 诚达药业股份有限公司 2024-04-09 CN claimed
EP-4132916-B1 SUBSTITUTED ISOPHTALIC ACID DIAMIDES AND THEIR USE AS HERBICIDES BAYER AG (DE) 2024-01-24 EP claimed
US-11786860-B2 Solvent composition for CO2 capture and a process mediated thereof INDIAN OIL CORPORATION LIMITED (IN) 2023-10-17 US claimed
US-20230180757-A1 SUBSTITUTED ISOPHTHALIC ACID DIAMIDES AND THEIR USE AS HERBICIDES BAYER AKTIENGESELLSCHAFT (DE) 2023-06-15 US claimed
CN-115656161-A Phthalic dicarboxaldehyde disinfectant concentration detection indicator card and preparation method thereof 利康医药科技江苏有限公司 2023-01-31 CN claimed
CN-115667231-A Substituted isophthalic acid diamides and their use as herbicides 拜耳公司 2023-01-31 CN claimed
WO-2007103687-A2 COMPOSITION AND METHOD FOR TOPICAL TREATMENT OF TAR-RESPONSIVE DERMATOLOGICAL DISORDERS TRISTRATA, INC. (US) 2007-09-13 WO claimed
US-20070207222-A1 COMPOSITION AND METHOD FOR TOPICAL TREATMENT OF TAR-RESPONSIVE DERMATOLOGICAL DISORDERS TRISTRATA, INC. (US) 2007-09-06 US claimed
EP-1685843-A1 Oligosaccharide aldonic acids and their topical use Yu, Ruey J., Dr. (US) 2006-08-02 EP claimed
EP-1227820-B1 OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE YU RUEY J (US) 2006-04-19 EP claimed
US-20040180854-A1 Oligosaccharide aldonic acids and their topical use YU RUEY J (US) 2004-09-16 US claimed
US-6740327-B2 USE FOR COSMETIC AND DERMATOLOGICAL INDICATIONS, REDUCING AND SOOTHING MUCOSA AND SKIN ERYTHEMA, INFLAMMATION OR REACTION CAUSED BY INTERNAL OR EXTERNAL FACTORS, WOUND HEALING, ETC. YU RUEY J (US) 2004-05-25 US claimed
EP-1227820-A2 OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE Yu, Ruey J., Dr. (US) 2002-08-07 EP claimed
US-20020028227-A1 Oligosaccharide aldonic acids and their topical use YU RUEY J (US) 2002-03-07 US claimed
US-6335023-B1 VEHICLES AND OLIGOSACCHARIDE ALDONIC ACIDS YU RUEY J (US) 2002-01-01 US claimed
WO-2001001932-A2 OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE YU RUEY J (US) 2001-01-11 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020028227-A1 Oligosaccharide aldonic acids and their topical use GLA, ALDOA, MAN2A1 PRCP 4316/4885DPP7 3192/4885SCN4A 3787/4885
US-20230180757-A1 SUBSTITUTED ISOPHTHALIC ACID DIAMIDES AND THEIR USE AS HERBICIDES DDT, DAO, IDH2 PRCP 3166/4885DPP7 197/4885SCN4A 2531/4885
US-20040180854-A1 Oligosaccharide aldonic acids and their topical use GLA, ALDOA, MAN2A1 PRCP 4316/4885DPP7 3192/4885SCN4A 3787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.